Clinical Trials Logo

Clinical Trial Summary

Expanded access Protocol to treat LHON subjects with EPI743


Clinical Trial Description

Emergency use administration of EPI-743 to subjects with LHON. This Protocol was originally developed to treat a single subject but was expanded to treat several at a single institution. ;


Study Design

N/A


Related Conditions & MeSH terms


NCT number NCT02300753
Study type Expanded Access
Source Edison Pharmaceuticals Inc
Contact
Status No longer available
Phase N/A

See also
  Status Clinical Trial Phase
Completed NCT01421381 - RHODOS Follow-up Single-visit Study N/A
Completed NCT00747487 - Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy Phase 2
Completed NCT04909398 - Pupil Dynamics and Color Vision for the Detection of Eye Diseases N/A
Completed NCT02693119 - A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for Treatment of Leber's Hereditary Optic Neuropathy Phase 2
Active, not recruiting NCT02161380 - Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy Phase 1
Withdrawn NCT01495715 - Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON) Phase 3
No longer available NCT04381091 - Expanded Access Program for Idebenone in Patients With Leber's Hereditary Optic Neuropathy Who Completed the LEROS Study